Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

C4 Therapeutics Inc.

United States 490 Arsenal Way Suite 120, 02472-2988, United States

About the sponsor

C4 Therapeutics Inc. is focused on solid tumorsBRAF-V600 mutations, with clinical interest spanning melanoma, non-small cell lung cancer, colorectal cancer, and anaplastic thyroid carcinoma.

  • Melanoma
  • Non-small cell lung cancer
  • Colorectal cancer
  • Anaplastic thyroid carcinoma

The sponsor’s clinical activity centers on tumors with the BRAF-V600 alteration, reflecting interest in genetically defined oncology populations across multiple disease settings.

About Specializations

C4 Therapeutics Inc. runs clinical trials in conditions such as Plasma cell myeloma refractory, Neoplasm, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Plasma cell myeloma refractory

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:C4 Therapeutics Inc.

Neoplasm

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:C4 Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.